Lv0
0 积分 2024-05-20 加入
[Chinese expert consensus on multidrug-resistant tuberculosis and Rifampicin-resistant tuberculosis treatment]
11小时前
已完结
Delamanid when other anti-tuberculosis-treatment regimens failed due to resistance or tolerability
11小时前
已完结
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
14小时前
已完结
皖公网安备34019202002308
